Clinical Trial: Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

Brief Summary: This study is conducted to investigate whether the efficacy of single-dose triple therapy (Esomeprazole 40 mg, Tinidazole 1 g, and Levofluxacine 500 mg) for 14 days is superior to double-dose lansoprazole 30 mg, amoxicillin 1 g and clarithromycin 500 mg for 14 days in the treatment of H pylori infection.